{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:24:10Z","timestamp":1759778650949},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p>The aim of this study was to compare the clinically based prevalence of myasthenia gravis (MG) with the prevalence of laboratory\u2010confirmed cases. All patients with a diagnosis of MG living in Estonia as on 1 January 1997 were asked to participate in re\u2010examination. The criteria for laboratory\u2010supported MG were weakness and rapid fatigue and a positive outcome of at least one of three laboratory tests: (i) blinded acetylcholinesterase inhibitor test; (ii) determination of antibodies to acetylcholine receptor and (iii) neurophysiological examination using repetitive nerve stimulation and single\u2010fibre EMG. Eighty\u2010nine patients were re\u2010examined and 70 patients (79%) fulfilled the criteria of laboratory\u2010supported MG. The corrected prevalence ratio was 78 per million. In the non\u2010confirmed MG group, there was more women (92%) than men (43%) whose diagnosis was established within 1\u2003year from onset of symptoms (<jats:italic>P<\/jats:italic>\u2003=\u20030.016). In all women with non\u2010confirmed MG the diagnosis was established within 1\u2003year from referral to the physician, whereas 68% of women with confirmed MG was diagnosed within 1\u2003year (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). Thus, we conclude that, in Estonia the prevalence of MG based on medical records seems overestimated by 21% and women are at higher risk of obtaining an uncertain diagnosis of MG.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2007.02038.x","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T14:01:12Z","timestamp":1202997672000},"page":"246-252","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical and laboratory\u2010reconfirmed myasthenia gravis: a population\u2010based study"],"prefix":"10.1111","volume":"15","author":[{"given":"M.","family":"\u00d6\u00f6pik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Puksa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.\u2010M.","family":"L\u00fc\u00fcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.\u2010E.","family":"Kaasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.12.1638"},{"key":"e_1_2_6_3_2","volume-title":"Statistical Yearbook of Estonia","author":"Statistical Office of Estonia","year":"1997"},{"key":"e_1_2_6_4_2","volume-title":"Aids to the Investigation of Peripheral Nerve Injury. War Memorandum N\u00ba45","author":"Medical Research Council","year":"1976"},{"key":"e_1_2_6_5_2","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty\u2010year experience in over 1200 patients","volume":"38","author":"Osserman KE","year":"1971","journal-title":"The Mount Sinai Journal of Medicine"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.10.1121"},{"key":"e_1_2_6_7_2","volume-title":"Acetylcholine Receptor Ab (ARAb) RRA. Radio Receptor Assay for the In\u2010vitro\u2010diagnostic Quantitative Determination of Autoantibodies against the Acetylcholine Receptor in Human Serum and Plasma","author":"IBL Immuno biological laboratories"},{"key":"e_1_2_6_8_2","volume-title":"Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice","author":"Kimura J","year":"1989"},{"key":"e_1_2_6_9_2","volume-title":"Single Fiber Electromyography","author":"St\u00e5lberg E","year":"1979"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150205"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000110529"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.9.1779"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1063-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530190081019"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150616"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050059"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.5.786"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4978.1259"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065882.63904.53"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052415"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.12.1246"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.41.5.394"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.1.255"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.4.492"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2007.02038.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2007.02038.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:38:42Z","timestamp":1696901922000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2007.02038.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,14]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1468-1331.2007.02038.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2007.02038.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,14]]},"assertion":[{"value":"2008-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}